Boston Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Boston Medical Center sits in the top decile of US sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count).
Boston Medical Center: 253 sponsored US clinical trials, 28 recruiting.
Boston Medical Center sponsors 253 registered US clinical trials on ClinicalTrials.gov, 28 of them currently recruiting, and 177 completed. 18 of these trials are in Phase 3-4 (later-stage) and 47 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 5 trials.
Top-decile sponsor footprint
Boston Medical Center ranks in the top decile of sponsors by registered trial count (#130 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
177 of 212 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
253 total, page 1 of 6
Stepped Care for Posttraumatic Stress Disorder Study
NCT06947538
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
NCT07137949
Behavior Analytic Support of Needle-related Hospital Visits for Autistic Patients
NCT06712784
Adapted Hospital Discharge Intervention: the CONNECT Pilot
NCT07032818
Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships
NCT07043426
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
NCT06732596
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
NCT06948838
A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk
NCT07022717
Simulation Trial of Telemedical Support for Paramedics
NCT06441760
Infectious Disease (ID) Testing OUtreach in Carceral Hubs
NCT06679751
Cervical Preparation for Same-Day Dilation & Evacuation
NCT06799052
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
NCT06812247
BoTox Into the Sternocleidomastoid Muscles (SCM)
NCT06903975
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
NCT06236607
Implementing a Pilot Patient Navigator Program to Improve Access to Infertility Care for Underserved Patients
NCT06481319
Sensory Outcomes in Active Substance Users
NCT06639438
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups
NCT06639386
Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)
NCT06489535
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
NCT05769218
Non-Invasive Monitoring Methods in Patients With Acute Brain Injury
NCT06504238
Integrative Mindfulness-Based Predictive Approach for Chronic Low Back Pain Treatment
NCT06106191
The Impact of Prehabilitation
NCT06181253
Intravascular Ultrasound in Patients With End-stage Renal Disease on Dialysis
NCT04399941
Right-Size Clinic Visits Using Memora Platform for PROMIS
NCT04441567
CenteringParenting Clinical Intervention on Kindergarten Readiness in Early Childhood
NCT03641092
Nutrition in Patient With Critical Limb Ischemia
NCT03529019
Neuroprognostication Bias: A Collaboration to Reduce the Impact of Self-fulfilling Prophecy in Cardiac ARrEst
NCT03261089
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
NCT00898235
Hypotensive Anesthesia for Orthognathic Surgery
NCT06093893
Parenting Intervention for Mothers With Substance Use Disorder
NCT06489522
Web-administered STAIR for Patients on Behavioral Health Waitlists
NCT06431022
Improving Access to Chiropractic Care in Community Health Centers
NCT06104605
Transitioning Together Boston
NCT05599711
Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old
NCT05329961
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
NCT04206813
Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate
NCT01508390
Carbohydrate Fluids and Post Operative Nausea and Vomiting
NCT06481670
Boston Medical Center Ultrasound Decongestion Study in Heart Failure
NCT07096726
Health-Related Social Needs Food Boxes Delivery Program
NCT07643909
Glaucoma Drop Aids Part 2
NCT06806332
Cardiac Anodal Biphasic Pacing
NCT07173777
A Novel Social Emotional Learning Curriculum for Youth With Epilepsy
NCT06427967
Prehospital Telemedicine Feasibility/Acceptability Pilot
NCT05967624
Tools to Improve Discharge Equity (TIDE) Pilot RCT
NCT05988229
Pre-exposure Prophylaxis (PrEP) Rapid Access
NCT05528562
Records for Alcohol Care Enhancement
NCT05492942
Proactive Therapeutic Drug Monitoring Based Adalimumab Therapy Optimization in Patients With Rheumatoid Arthritis
NCT05460390
Total Joint Arthroplasty (TJA) Weight Loss Study
NCT05156762
Tuberculosis - Learning the Effect of Parasites and Reinforcing Diets
NCT05048485
Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV
NCT05020899
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 23 |
| Phase 2 | 24 |
| Phase 3 | 9 |
| Phase 4 | 9 |
Therapeutic Areas
What is open in the Boston Medical Center pipeline
28 recruiting of 253 indexed (11% open); 177 completed (70%).
Phase mix: 18 late (III/IV) vs 47 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Boston Medical Center: open-pipeline peers nationwide
Peers matched on 253 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Boston Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 253 trials (± recruiting share)
- University of South Florida · 252 trials · 17% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Masonic Cancer Center, University of Minnesota · 249 trials · 14% recruiting
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
Sponsors near 11% open enrollment (± trial volume)
- The Miriam Hospital · 11% recruiting · 136 trials
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
Related
What to do with this Boston Medical Center page
253 registered trials is a research-attention snapshot, not an endorsement of Boston Medical Center or any single study.
- 28 of Boston Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Boston Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Boston Medical Center pipeline card: 253 registered trials from official public datasets.Report a data error.